get semaglutide in canada approves first generic version of Ozempic amid rising GLP-1 competition Health Canada approves first GLP-1
Description
He et al., 2022)
We thank our funders, the Novo Nordisk ISS Scheme, the National Institute for Health Research (NIHR) UCL/UCLH Biomedical Research Centre and the Sir Jules Thorne Charitable Trust, for supporting our work
It was a bezoar, which affects at most 4 in 1,000 people
A product sold online under the same name is not equivalent to participation in a regulated trial, where product quality, eligibility, monitoring and adverse-event reporting are controlled
Nauck MA, Vilsbll T, Gallwitz B, Garber A, Madsbad S (2009) Incretin-based therapies
